This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Teladoc (TDOC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $194.71 in the latest trading session, marking a +0.7% move from the prior day.
Centene Ties Up to Expand Telehealth Services in Rural Areas
by Zacks Equity Research
Centene (CNC) partners with Samsung Electronics America to make telehealth offerings available in rural and underserved areas.
Cigna (CI) Enhances Offerings in the Individual Exchange
by Zacks Equity Research
Cigna's (CI) health plans with enhanced features will not only expand its customer reach by 27% but also strengthen its presence on the individual exchange.
Magellan, Livongo's Solution to Enhance Behavioral Health
by Zacks Equity Research
Magellan (MGLN) collaborates with Livongo, which provides Magellan customers and members access to a digital self-care solution, Livongo for Behavioral Health.
Most Interesting New ETFs: Sports Betting & Telemedicine
by Neena Mishra
We highlight the first sports betting ETF and a digital health ETF
Cigna and Dignity Health Sign New Deal to Serve Patients
by Zacks Equity Research
Cigna's (CI) collaboration with Dignity Health intends to provide improved health outcomes for the California and Nevada communities.
Teladoc (TDOC) Down 9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Teladoc Health to Merge With Livongo to Improve Services
by Zacks Equity Research
Teladoc Health (TDOC) to merge with Livongo in a cash-stock deal valued at $18.5 billion, which is likely to result in improved virtual healthcare services.
ETFs Set to Surge on Virtual Healthcare Deal
by Sweta Killa
The ongoing boom in online care and consultations has led to merger & acquisition activity in the telehealth services space.
Should Goldman Sachs Equal Weight U.S. Large Cap Equity ETF (GSEW) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for GSEW
Teladoc (TDOC) Q2 Earnings Lag Estimates, Revenues Up Y/Y
by Zacks Equity Research
Teladoc's (TDOC) second-quarter results reflect higher revenues and solid rise in patient visits, partially offset by increased expenses.
Teladoc (TDOC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Teladoc (TDOC) delivered earnings and revenue surprises of -47.83% and 9.45%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
5 Healthcare Stocks to Beat on Q2 Earnings Despite Coronavirus
by Zacks Equity Research
Companies across the healthcare sector experience a mixed impact from coronavirus. While some gain traction from a surge in virtual care, the rest suffers demand woes and supply-chain glitches.
Teladoc (TDOC) Q2 Earnings to Gain From Coronavirus-Led Demand
by Zacks Equity Research
Teladoc Health (TDOC) Q2 earnings are likely to have gained from higher virtual health visits and membership growth from coronavirus-led demand.
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed the most recent trading day at $223.98, moving -1.18% from the previous trading session.
Teladoc (TDOC) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
by Zacks Equity Research
Teladoc (TDOC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Large-Cap MedTech Stocks to Buy on Northbound Market Trend
by Sriparna Ghosal
Backed by an upward trend of share prices and projections of robust earnings growth rates, there are a few MedTech stocks which are ideal for long-term bet.
Teladoc (TDOC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $218.56 in the latest trading session, marking a -1.47% move from the prior day.
The Zacks Analyst Blog Highlights: Teladoc Health, Zoom Video Communications, Amazon, Costco Wholesale and Fiverr International
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Teladoc Health, Zoom Video Communications, Amazon, Costco Wholesale and Fiverr International
4 Telehealth Stocks to Gain on Virtual Response to Coronavirus
by Sreoshi Bera
Advancement in technology has helped cater to the growing medical demand during the coronavirus pandemic. Here are four telehealth stocks set to boom.
The Zacks Analyst Blog Highlights: California-based Fortinet, Fastly, Teladoc Health, DocuSign and Zoom Video Communications
by Zacks Equity Research
The Zacks Analyst Blog Highlights: California-based Fortinet, Fastly, Teladoc Health, DocuSign and Zoom Video Communications
Investing in New Normal: 3 Major Trends That Are Here to Stay
by Urmimala Biswas
There has been a huge change in livelihood and lifestyle, thanks to the coronavirus outbreak.
Teladoc (TDOC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $228.43 in the latest trading session, marking a +1.74% move from the prior day.
Tap the Rising Remote-Work Trend With These 5 Stocks
by Tirthankar Chakraborty
The work-from-home trend that began as a momentary way to keep employees safe is now becoming a permanent initiative for large companies who look to curtail office rents and tap talent pool.
6 Top Large-Cap Stocks With More Than 100% Return YTD
by Nalak Das
A handful of large-cap companies with a favorable Zacks Rank have skyrocketed more than 100% YTD, defying coronavirus-induced economic devastations.